These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Health care associated Clostridioides difficile infection and colonization in patients admitted at tertiary care hospital Pakistan. Ahmed A; Ikram A; Sabir N; Zaman G; Gardeezi A; Satti L J Pak Med Assoc; 2022 Apr; 72(4):610-615. PubMed ID: 35614587 [TBL] [Abstract][Full Text] [Related]
48. Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case-control study. Kim MH; Kim YC; Kim JL; Park YS; Kim H BMC Infect Dis; 2022 Jan; 22(1):104. PubMed ID: 35093016 [TBL] [Abstract][Full Text] [Related]
49. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? Hawes AM; Desai A; Patel PK Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702 [TBL] [Abstract][Full Text] [Related]
50. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea. Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839 [TBL] [Abstract][Full Text] [Related]
51. A prospective, observational study of fidaxomicin use for Guery B; Berger P; Gauzit R; Gourdon M; Barbut F; ; Dafne Study Group ; Bémer P; Bessède E; Camou F; Cattoir V; Couzigou C; Descamps D; Dinh A; Laurans C; Lavigne JP; Lechiche C; Leflon-Guibout V; Le Monnier A; Levast M; Mootien JY; N'Guyen Y; Piroth L; Prazuck T; Rogeaux O; Roux AL; Vachée A; Vernet Garnier V; Wallet F J Int Med Res; 2021 Jun; 49(6):3000605211021278. PubMed ID: 34162264 [TBL] [Abstract][Full Text] [Related]
52. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. McFarland LV; Ozen M; Dinleyici EC; Goh S World J Gastroenterol; 2016 Mar; 22(11):3078-104. PubMed ID: 27003987 [TBL] [Abstract][Full Text] [Related]
53. A Cross-Sectional Study of Clostridium Difficile Infection in Inpatients with Antibiotic Associated Diarrhea. Ma X; Li Z; Zheng Y; Fang L; Lin H; Xu H; Hong G Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057925 [TBL] [Abstract][Full Text] [Related]
55. Clostridioides difficile Colitis. Pumiglia L; Wilson L; Rashidi L Surg Clin North Am; 2024 Jun; 104(3):545-556. PubMed ID: 38677819 [TBL] [Abstract][Full Text] [Related]
56. MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets. Steele J; Zhang Q; Beamer G; Butler M; Bowlin T; Tzipori S Antimicrob Agents Chemother; 2013 Aug; 57(8):4039-41. PubMed ID: 23689716 [TBL] [Abstract][Full Text] [Related]
57. The mechanisms and safety of probiotics against toxigenic Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637 [TBL] [Abstract][Full Text] [Related]
58. Emerging alternatives against Clostridioides difficile infection. Romero-Rodríguez A; Martínez de la Peña C; Troncoso-Cotal S; Guzmán C; Sánchez S Anaerobe; 2022 Dec; 78():102638. PubMed ID: 36210608 [TBL] [Abstract][Full Text] [Related]
59. Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model. Chilton CH; Crowther GS; Miossec C; de Gunzburg J; Andremont A; Wilcox MH J Antimicrob Chemother; 2020 Jun; 75(6):1458-1465. PubMed ID: 32097465 [TBL] [Abstract][Full Text] [Related]
60. Pathogenicity and virulence of Buddle JE; Fagan RP Virulence; 2023 Dec; 14(1):2150452. PubMed ID: 36419222 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]